Analysts expect that Docusign Inc (NASDAQ:DOCU) will report $220.11 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Docusign’s earnings. The lowest sales estimate is $219.20 million and the highest is $221.00 million. Docusign reported sales of $167.04 million during the same quarter last year, which indicates a positive year over year growth rate of 31.8%. The company is expected to issue its next quarterly earnings report on Wednesday, September 4th.
On average, analysts expect that Docusign will report full-year sales of $919.85 million for the current fiscal year, with estimates ranging from $919.00 million to $921.50 million. For the next year, analysts anticipate that the company will report sales of $1.13 billion, with estimates ranging from $1.12 billion to $1.15 billion. Zacks’ sales calculations are an average based on a survey of research firms that that provide coverage for Docusign.
Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, June 6th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.23) by $0.30. The company had revenue of $213.96 million during the quarter, compared to analyst estimates of $208.15 million. Docusign had a negative net margin of 26.54% and a negative return on equity of 22.27%. Docusign’s quarterly revenue was up 37.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.01 earnings per share.
Several research firms have commented on DOCU. Wedbush lifted their price objective on shares of Docusign from $48.00 to $59.00 and gave the stock a “neutral” rating in a research note on Friday, March 15th. Piper Jaffray Companies lifted their target price on Docusign from $50.00 to $61.00 and gave the stock an “overweight” rating in a research report on Monday, March 11th. ValuEngine downgraded Docusign from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, May 8th. Finally, William Blair reiterated an “outperform” rating on shares of Docusign in a research report on Friday, June 7th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Docusign currently has a consensus rating of “Buy” and an average target price of $61.50.
In other news, CRO Loren Alhadeff sold 11,579 shares of Docusign stock in a transaction on Wednesday, June 19th. The stock was sold at an average price of $53.12, for a total transaction of $615,076.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Scott V. Olrich sold 10,000 shares of Docusign stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $54.85, for a total value of $548,500.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 51,579 shares of company stock valued at $2,766,276. Corporate insiders own 13.60% of the company’s stock.
Several large investors have recently added to or reduced their stakes in DOCU. Rhumbline Advisers grew its holdings in shares of Docusign by 153.1% in the 4th quarter. Rhumbline Advisers now owns 74,570 shares of the company’s stock valued at $2,989,000 after buying an additional 45,104 shares during the period. BB&T Securities LLC acquired a new position in shares of Docusign in the 4th quarter valued at $269,000. Chicago Equity Partners LLC acquired a new position in shares of Docusign in the 4th quarter valued at $498,000. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Docusign by 16.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 57,415 shares of the company’s stock valued at $2,301,000 after buying an additional 8,242 shares during the period. Finally, Parallel Advisors LLC grew its holdings in shares of Docusign by 244.1% in the 4th quarter. Parallel Advisors LLC now owns 905 shares of the company’s stock valued at $36,000 after buying an additional 642 shares during the period. Institutional investors and hedge funds own 61.15% of the company’s stock.
NASDAQ DOCU traded down $1.18 on Thursday, hitting $49.83. 1,598,692 shares of the stock were exchanged, compared to its average volume of 2,414,584. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 1.00. The business has a fifty day moving average price of $52.60. The stock has a market capitalization of $8.82 billion, a price-to-earnings ratio of -17.18 and a beta of 1.77. Docusign has a 52-week low of $35.06 and a 52-week high of $68.35.
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Further Reading: Short Selling Stocks, A Beginner’s Guide
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.